0001209191-21-053227.txt : 20210824
0001209191-21-053227.hdr.sgml : 20210824
20210824183024
ACCESSION NUMBER: 0001209191-21-053227
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201120
FILED AS OF DATE: 20210824
DATE AS OF CHANGE: 20210824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEPTULA-HICKS DARLENE M
CENTRAL INDEX KEY: 0001089409
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 211203207
MAIL ADDRESS:
STREET 1: C/O ICAD, INC.
STREET 2: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: F-star Therapeutics, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 44 1223 497400
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130108
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-11-20
2020-11-24
0
0001566373
F-star Therapeutics, Inc.
FSTX
0001089409
DEPTULA-HICKS DARLENE M
C/O F-STAR THERAPEUTICS, INC.
EDDEVA B920, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
1
0
0
Treasurer and CFO
Common Stock
2020-11-20
4
A
0
26437
0.00
A
26437
D
This amendment to the Form 4 filed on November 24, 2020 is being filed solely to report the ownership of the restricted stock units ("RSUs") received by the Reporting Person in Table I of this Form 4 rather than in Table II as originally reported. No additional grants of securities are reported hereby.
The securities awarded are in the form of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five per cent (25%) of the total number of shares under the award shall vest on the first anniversary of the "Vesting Commencement Date," July 1, 2020, and two and one twelfth per cent (2.083%) of the total number of shares under the award shall vest monthly thereafter, provided in each case that the Reporting Person remains a service provider of the Issuer continuously from the Vesting Commencement Date to the relevant date.
/s/ Darlene Deptula-Hicks
2021-08-24